|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal Susitarimą)
| (51) | INT.CL. | C07K 16/28 | |
| C12N 5/071 | |||
| G01N 33/53 | |||
| G01N 33/68 |
| (11) | Patento numeris | 1141028 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 99966644.9 |
| Europos patento paraiškos padavimo data | 1999-12-23 | |
| (97) | Europos patento paraiškos paskelbimo data | 2001-10-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2010-02-17 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US1999/030895 |
| Data | 1999-12-23 |
| (87) | Numeris | WO 2000/037504 |
| Data | 2000-06-29 |
| (30) | Numeris | Data | Šalis |
| 113647 P | 1998-12-23 | US |
| (72) |
HANSON, Douglas, Charles, US
NEVEU, Mark, Joseph, US
MUELLER, Eileen, Elliot, US
HANKE, Jeffrey, Herbert, US
GILMAN, Steven, Christopher, US
DAVIS, C., Geoffrey, US
CORVALAN, Jose, Ramon, US
|
| (73) |
Pfizer Inc.,
235 East 42nd Street, New York, NY 10017,
US
Amgen Fremont Inc., 6701 Kaiser Drive, Fremont, CA 94555, US |
| (54) | HUMAN MONOCLONAL ANTIBODIES TO CTLA-4 |
| HUMAN MONOCLONAL ANTIBODIES TO CTLA-4 |